Revolution Medicines, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 16.61 M | $587.40 M | -2.83% | 8.83% |
BLACKROCK, INC. | 05/02/2025 | 14.69 M | $519.52 M | -0.18% | 7.81% |
FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 13.53 M | $478.59 M | 2.16% | 7.19% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 11.79 M | $416.82 M | 8.93% | 6.27% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 10.19 M | $380.57 M | 7.44% | 5.42% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 7.94 M | $280.65 M | 0.00% | 4.22% |
05/15/2025 | 7.60 M | $268.77 B | 100.00% | 4.04% | |
FMR LLC | 05/12/2025 | 7.54 M | $266.46 M | 11.77% | 4.01% |
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 6.18 M | $218.46 M | -5.72% | 3.28% |
STATE STREET CORP | 05/15/2025 | 5.80 M | $205.26 M | 0.23% | 3.09% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 5.60 M | $198.00 M | -4.54% | 2.98% |
BVF INC/IL | 05/15/2025 | 4.98 M | $176.18 M | 19.16% | 2.65% |
BELLEVUE GROUP AG | 05/14/2025 | 4.37 M | $154.68 M | -0.29% | 2.33% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 4.14 M | $146.51 M | 1.38% | 2.20% |
ALPHABET INC. | 05/02/2025 | 4.13 M | $146.15 M | 0.00% | 2.20% |
WOODLINE PARTNERS LP | 05/15/2025 | 3.89 M | $137.45 M | 0.03% | 2.07% |
JPMORGAN CHASE & CO | 05/12/2025 | 3.70 M | $130.93 M | -3.30% | 1.97% |
CASDIN CAPITAL, LLC | 05/15/2025 | 3.70 M | $130.76 M | -0.04% | 1.97% |
HOLOCENE ADVISORS, LP | 05/15/2025 | 3.69 M | $130.54 M | 23.19% | 1.96% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 3.32 M | $117.30 M | 1.81% | 1.76% |
AH CAPITAL MANAGEMENT, L.L.C. | 05/15/2025 | 2.75 M | $97.19 M | 0.00% | 1.46% |
04/25/2025 | 2.20 M | $77.66 B | 100.00% | 1.17% | |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 2.16 M | $76.54 M | -17.70% | 1.15% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.93 M | $68.26 M | -0.03% | 1.03% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.72 M | $60.71 M | 2.30% | 0.91% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 1.67 M | $59.17 M | 100.00% | 0.89% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 1.60 M | $56.58 M | 10.34% | 0.85% |
NORTHERN TRUST CORP | 05/13/2025 | 1.53 M | $54.27 M | -0.35% | 0.82% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 1.49 M | $52.71 M | -8.37% | 0.79% |
05/15/2025 | 1.32 M | $46.60 M | -69.20% | 0.70% | |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 1.28 M | $45.32 M | 5.64% | 0.68% |
MORGAN STANLEY | 05/15/2025 | 1.26 M | $44.40 M | 46.30% | 0.67% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 05/09/2025 | 1.06 M | $37.62 M | 18,248.78% | 0.57% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 997.46 K | $35.27 M | 0.00% | 0.53% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 750.67 K | $26.54 M | 0.00% | 0.40% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 747.56 K | $26.44 M | 4.91% | 0.40% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 741.86 K | $26.23 M | 15.62% | 0.39% |
FINEPOINT CAPITAL LP | 05/14/2025 | 691.26 K | $24.44 M | -2.68% | 0.37% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 656.18 K | $23.20 M | 3.96% | 0.35% |
CANDRIAM S.C.A. | 05/14/2025 | 655.13 K | $23.17 M | -0.24% | 0.35% |
CITIGROUP INC | 05/12/2025 | 609.39 K | $21.55 M | 127.00% | 0.32% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 582.72 K | $20.61 M | 2.41% | 0.31% |
SIREN, L.L.C. | 05/23/2025 | 563.76 K | $19.93 M | -1.36% | 0.30% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 524.43 K | $18.54 M | 111.19% | 0.28% |
MIC CAPITAL MANAGEMENT UK LLP | 05/15/2025 | 508.57 K | $17.98 M | 0.00% | 0.27% |
UBS GROUP AG | 05/13/2025 | 482.11 K | $17.05 M | 60.82% | 0.26% |
05/12/2025 | 477.86 K | $16.90 M | 100.00% | 0.25% | |
CALIGAN PARTNERS LP | 05/15/2025 | 465.00 K | $16.44 M | 100.00% | 0.25% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 446.56 K | $15.79 M | 11.35% | 0.24% |
ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 427.47 K | $15.12 M | 40.07% | 0.23% |
Revolution Medicines, Inc. institutional Ownership - FAQ's
During the previous two years, 305 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:
EXCHANGE TRADED CONCEPTS, LLC: 0
Beacon Capital Management, LLC: 0
WOLFF WIESE MAGANA LLC: 0
VANGUARD GROUP INC: 16.61 M
BlackRock, Inc.: 14.69 M
FARALLON CAPITAL MANAGEMENT LLC: 13.53 M
101.55% of Revolution Medicines, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 218.95 M shares in the last 24 months. This purchase volume represents approximately $8.38 B in transactions.